about
Polymorphisms in immunoregulatory genes and the risk of histologic chorioamnionitis in Caucasoid women: a case control studyMannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation.CREST maps somatic structural variation in cancer genomes with base-pair resolution.Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.The genomic landscape of hypodiploid acute lymphoblastic leukemia.COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia.Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome.Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant.Heteroligomeric forms of codon 54 mannose binding lectin (MBL) in circulation demonstrate reduced in vitro function.High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALL.Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia.Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment.Donor Mannose‐Binding Lectin Deficiency Increases the Likelihood of Clinically Significant Infection after Liver TransplantationMannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantationMannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivityInterleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-β, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birthAnalysis of the Relationship Between Mannose-Binding Lectin (MBL) Genotype, MBL Levels and Function in an Australian Blood Donor PopulationA Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with LeukemiaActivating killer-cell immunoglobulin-like receptor haplotype influences clinical outcome following HLA-matched sibling haematopoietic stem cell transplantationLow mannose-binding lectin function is associated with sepsis in adult patientsClinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblingsMannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patientsHigh levels of mannose-binding lectin are associated with poor outcomes after lung transplantation
P50
Q24801772-85132877-9403-4FDB-ADB1-A299A13FAA9BQ34621964-F1155131-4D35-4342-B49C-6226BE86B5FEQ36480006-BEBE5585-91E5-4E6D-BBF1-9EB431843870Q36708679-051250C0-2405-4C9D-9C00-7CB1D97C0450Q37574743-686E10B3-58C4-4B51-A251-E6C608D903E9Q37619704-233E212D-9C04-4222-8DD0-95EB4393F42CQ39018401-CD997549-8EF8-482A-88A3-91442B449078Q40565040-EB3E150A-FC9D-4FA1-824B-9F6B38AC8C74Q42226188-FDB6F711-F6E4-4471-A9AA-4C48DAAAB852Q46649242-ECBDF46E-6A01-4FC7-BA8B-E2427555F3D7Q47142310-C445FA10-BB63-4832-8D01-D8713A8DED06Q47660672-B390E064-D369-488C-9B71-AE89EDE8C12EQ47762458-8FDEEED5-267B-4C51-9AB8-FA129D624B04Q47864993-4BF4BBBA-588E-47D1-9111-CB7F43EB8921Q52659464-77B582FA-BA5F-4BF9-A805-15B3A823DAA8Q53100287-8319DBF5-90D1-4E9A-A156-CD0085B06A51Q53793874-F1038A9A-34BE-4875-A8E3-6273FA7A3DEDQ54325684-1A37BB49-9D52-439B-9D88-E37C5BC37FD1Q57734284-9F6B651B-90C7-416A-AE92-F443CEC736DEQ57734329-41F6B245-C8EA-4D05-A4F5-715AA9B18E32Q57734342-8233B06E-A05C-4CF9-AC1E-45B3984FF654Q57734366-BE61EB29-3F94-4705-9002-74FAE98917F0Q57734377-1BC776E8-821F-4A2B-B8D9-60F5761E477EQ59236227-B72064E3-18EB-4A5E-B144-09060EC43304Q61795638-C0C26F68-08D2-4825-94D3-8C9D14B1FAFFQ64131020-10D4276F-60F9-468F-8FB9-DDDC6297F59DQ73669446-86902E3C-7E25-482F-8A93-55A3F87BE74CQ81094069-1AE71AE9-A3D9-4982-B4A9-87231BF8F8A2Q83586186-4BC3400E-AD6F-4B0D-BB2E-446D9ECF38FC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Susan L. Heatley
@ast
Susan L. Heatley
@en
Susan L. Heatley
@es
Susan L. Heatley
@nl
Susan L. Heatley
@sl
type
label
Susan L. Heatley
@ast
Susan L. Heatley
@en
Susan L. Heatley
@es
Susan L. Heatley
@nl
Susan L. Heatley
@sl
prefLabel
Susan L. Heatley
@ast
Susan L. Heatley
@en
Susan L. Heatley
@es
Susan L. Heatley
@nl
Susan L. Heatley
@sl
P106
P1153
6701421050
P21
P31
P496
0000-0001-7497-6477